We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Nuvelo today announced that it has entered a new development collaboration with
the Pharmaceutical Division of Kirin Brewery Co. to advance a potent growth
factor, NU206, which entered IND-enabling studies late in 2004.
Switzerland-based Novartis AG has signed a three-year agreement with the Thai
government agency Biotec aimed at developing new medicines based on indigenous
natural compounds and microorganisms.
Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa
Pharmaceutical Co., Ltd. were merged last week by combining operations into
a new corporation named Astellas Pharma Inc.
The Indian government is studying plans to ease the entry of drug
companies, including Dr. Reddy's and Hetero, into the Tunisian market, partly
as a means to increase access to the European Union (EU).
Senior health officials in Brazil have accepted recent criticism
of the state-run drug-manufacturing sector, which was recently blamed for an
acute shortage of essential medicines earlier this year.
India's National Pharmaceutical Pricing Authority (NPPA) has reduced
prices on 22 bulk drugs and 16 "derivative" products, purportedly
to account for a reduction in taxes under the latest national budget.
The collaboration aims to develop improved interferon alpha protein therapeutics
to treat hepatitis C virus (HCV) and hepatitis B virus (HBV) infections.